![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 1.790
- -0.090-4.79%
Close Feb 25 16:00 ET
- 1.850
- +0.060+3.35%
Post 20:01 ET
476.36MMarket Cap-1.47P/E (TTM)
1.920High1.790Low1.87MVolume1.900Open1.880Pre Close3.42MTurnover1.36%Turnover RatioLossP/E (Static)266.12MShares6.62552wk High1.00P/B246.02MFloat Cap1.79052wk Low--Dividend TTM137.44MShs Float53.240Historical High--Div YieldTTM6.92%Amplitude1.600Historical Low1.832Avg Price1Lot Size
Autolus Therapeutics Stock Forum
Sign in to post a comment
$Autolus Therapeutics (AUTL.US)$ Autolus Therapeutics to Present Key Data on AUCATZYL At 2025 Tandem Meetings, Highlighting Cost Benefits and Clinical Outcomes! February 12 to 15, 2025
4
2
$Autolus Therapeutics (AUTL.US)$
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics (NASDAQ: AUTL)presented clinical data updates at ASH 2024, featuring one oral and three poster presentations about obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
The FELIX trial demonstrated that obe-cel treatment achieved deep molecular remission in 84% of responde...
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics (NASDAQ: AUTL)presented clinical data updates at ASH 2024, featuring one oral and three poster presentations about obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
The FELIX trial demonstrated that obe-cel treatment achieved deep molecular remission in 84% of responde...
1
$Autolus Therapeutics (AUTL.US)$ Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 6 to 8 PM pst 12/9/24!
4 MINUTES AGO, 7:30 PM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 7:30 PM EST
VIA GLOBENEWSWIRE
1
$Autolus Therapeutics (AUTL.US)$ Nothing happened?
2
1
$Autolus Therapeutics (AUTL.US)$
ya I'm getting in here
ya I'm getting in here
1
2
$Autolus Therapeutics (AUTL.US)$
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
• AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy)
• Approval based on FELIX clinical trial of obe-cel in adult patients with r/r B-ALL
• Conference call to be held on November 11 at 08:30 am EST/13:3...
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
• AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy)
• Approval based on FELIX clinical trial of obe-cel in adult patients with r/r B-ALL
• Conference call to be held on November 11 at 08:30 am EST/13:3...
3
No comment yet
blessings u : Thank you for sharing.
Trytosaveabit OP blessings u : you’re welcome![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")